Evidence map›Paper›PMID 38768334›Full record

ArticleDiabetes care2024

Treatment of Diabetes in Hospitals With Noninsulin Medications Is a Research Priority.

Daisy Duan, Nestoras N Mathioudakis, Scott J Pilla

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Daisy DuanDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Nestoras N MathioudakisDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-0210-655X
Scott J PillaDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-3292-9047

Funding

Supplement to Effectiveness of Digital Versus In-Person Diabetes Prevention ProgramsR01DK125780 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MATHIOUDAKIS, NESTORAS N · 2020 to 2023
$3.0M
Developing and validating EHR-integrated readmission risk prediction models for hospitalized patients with diabetesR01DK122073 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI RUBIN, DANIEL J · 2020 to 2024
$2.8M
Implementation of a diabetes navIgator to Mitigate disPArities and improve CGM upTake and sustained use across the lifespan of T1D (IMPACT T1D)R01DK134955 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MATHIOUDAKIS, NESTORAS N, WOLF, RISA MICHELLE · 2022 to 2025
$1.8M
Metabolic Effects of Circadian-Based Dinner TimeK23DK133690 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Daisy Duan · 2022 to 2026
$1.0M
An intervention to enhance hypoglycemia communication and preventive action in primary careK23DK128572 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI PILLA, SCOTT · 2021 to 2024
$790k
NIDDK NIH HHS K23 DK128572NIDDK NIH HHS K23DK128572NIDDK NIH HHS K23 DK133690NIDDK NIH HHS R01 DK122073NIDDK NIH HHS R01 DK125780NIDDK NIH HHS R01 DK134955
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes MellitusHypoglycemic AgentsHumansHypoglycemic Agents

Identifiers

PMID38768334
PMCPMC11116904

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.